miR-137 regulates the migration of human umbilical vein endothelial cells by targeting ephrin-type A receptor 7

Molecular Medicine Reports

Volumn 10, Issue 3, 2014, Pages 1475-1480

  Lu, Yucheng ^a   Heng, Xueyuan ^a   Yu, Jixu ^a   Su, Quanping ^a   Guan, Xianghong ^a   You, Cuiping ^a   Wang, Long ^a   Che, Fengyuan ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Angiogenesis; Cell migration; Cell viability; Ephrin type A receptor 7; Human umbilical vein endothelial cells; MicroRNA 137

Indexed keywords

EPHRIN RECEPTOR A7; MESSENGER RNA; MICRORNA; MICRORNA 137; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; MIRN137 MICRORNA, HUMAN; TETRAZOLIUM; THIAZOLE DERIVATIVE; THIAZOLYL BLUE;

3' UNTRANSLATED REGION; ANGIOGENESIS; ARTICLE; BINDING SITE; BIOINFORMATICS; CAPILLARY PROLIFERATION; CELL MIGRATION; CELL VIABILITY; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; UMBILICAL VEIN ENDOTHELIAL CELL; BIOLOGY; CELL MOTION; CELL SURVIVAL; DIAGNOSTIC USE; GENE EXPRESSION REGULATION; GENE TARGETING; GENETICS; METABOLISM; NEOVASCULARIZATION (PATHOLOGY);

3' UNTRANSLATED REGIONS; BINDING SITES; CELL MOVEMENT; CELL SURVIVAL; COMPUTATIONAL BIOLOGY; GENE EXPRESSION REGULATION; GENE TARGETING; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MICRORNAS; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; RECEPTOR, EPHA7; TETRAZOLIUM SALTS; THIAZOLES;

EID: 84905440289     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2014.2319     Document Type: Article

References (26)

1. Carmeliet P: VEGF as a key mediator of angiogenesis in cancer. Oncology 69: 4-10, 2005.
2. Eulalio A, Huntzinger E and Izaurralde, E: Getting to the root of miRNA-mediated gene silencing. Cell 132: 9-14, 2008.
3. Suarez Y and Sessa WC: MicroRNAs as novel regulators of angiogenesis. Circ Res 104: 442-454, 2009.
4. Donnem T, Fenton CG, Lonvik K, Berg T, Eklo K, Andersen S, Stenvold H, AI-Shibli K, AI-Saad S, Bremnes RM and Busund LT: MicroRNA signatures in tumor tissue related to angiogenesis in non-small cell lung cancer. Plos One 7: e29671, 2012.
5. Yamasaki K, Nakasa T, Miyaki S, Yamasaki T, Yasunaqa Y and Ochi M: Angiogenic microRNA-210 is present in cells surrounding osteonecrosis. J Orthop Res 30: 1263-1270, 2012.
6. Yang WJ, Yang DD, Na S, Sandusky GE, Zhang Q and Zhao G: Dicer is required for embryonic angiogenesis during mouse development. J Biol Chem 280: 9330-9335, 2005. (Pubitemid 40409626)
7. Kuehbacher A, Urbich C, Zeiher AM and Dimmeler S: Role of Dicer and Drosha for endothelial microRNA expression and angiogenesis. Circ Res 101: 59-68, 2007. (Pubitemid 47094624)
8. Suárez Y, Fernández-Hernando C, Pober JS and Sessa WC: Dicer dependent microRNAs regulate gene expression and functions in human endothelial cells. Circ Res 100: 1164-1173, 2007. (Pubitemid 46684129)
9. Fasanaro P, D'Alessandra Y, Di Stefano V, Melchionna R, Romani S, Pompilio G, Capogrossi MC and Martelli F: MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand Ephrin-A3. J Biol Chem 283: 15878-15883, 2008.
10. Harris TA, Yamakuchi M, Ferlito M, Mendell JT and Lowenstein CJ: MicroRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1. Proc Natl Acad Sci USA 105: 1516-1521, 2008. (Pubitemid 351346546)
11. Poliseno L, Tuccoli A, Mariani L, Evangelista M, Citti L, Woods K, Mercatanti A, Hammond S and Rainaldi G: MicroRNAs modulate the angiogenic properties of HUVECs. Blood 108: 3068-3071, 2006.
12. Würdinger T, Tannous BA, Saydam O, Skog J, Grau S, Soutschek J, Weissleder R, Breakefield XO and Krichevsky AM: miR-296 regulates growth factor receptor overexpression in angiogenic endothelial cells. Cancer Cell 14: 382-393, 2008.
13. le Sage C, Nagel R, Egan DA, Schrier M, Mesman E, Mangiola A, Anile C, Maira G, Mercatelli N, Ciafrè SA Farace MG and Agami R: Regulation of the p27(Kip1) tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation. EMBO J 26: 3699-3708, 2007. (Pubitemid 47236875)
14. Bonauer A, Carmona G, Iwasaki M, et al: MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice. Science 324: 1710-1713, 2009.
15. Ribatti D, Nico B, Vacca A and Presta M: The gelatin sponge- chorioallantoic membrane assay. Nat Protoc 1: 85-91, 2006.
16. Wang HU, Chen ZF and Anderson DJ: Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4. Cell 93: 741-753, 1998. (Pubitemid 28257581)
17. Ogawa K, Pasqualini R, Lindberg RA, Kain, Freeman AL, Pasquale EB: The ephrin-A1 ligand and its receptor, EphA2, are expressed during tumor neovascularization. Oncogene 19: 6043-6052, 2000. (Pubitemid 32039378)
18. Stadler HS, Higgins KM, Capecchi MR: Loss of Eph-receptor expression correlates with loss of cell adhesion and chondrogenic capacity in Hoxa13 mutant limbs. Development 128: 4177-4188, 2001. (Pubitemid 33077030)
19. Chan J, Mably JD, Serluca FC, Chen JN, Goldstein NB, Thomas MC, Cleary JA, Brennan C, Fishman MC and Roberts TM: Morphogenesis of prechordal plate and notochord requires intact Eph/ephrinB signaling. Dev Bio 234: 470-482, 2001. (Pubitemid 32552672)
20. Dravis C, Yokoyama N, Chumley MJ, Cowan CA, Silvany RE, Shay J, Baker LA and Henkemeyer M: Bidirectional signaling mediated by ephrin-B2 and EphB2 controls urorectal development. Dev Biol 271: 272-290, 2004. (Pubitemid 38833661)
21. Davy A, Aubin J and Soriano P: Ephrin-B1 forward and reverse signaling are required during mouse development. Genes Dev 18: 572-583, 2004. (Pubitemid 38372813)
22. Marquardt T, Shirasaki R, Ghosh S, Andrews SE, Carter N, Hunter T and Pfaff SL: Coexpressed EphA receptors and ephrin-A ligands mediate opposing actions on growth cone navigation from distinct membrane domains. Cell 121: 127-139, 2005.
23. Egea J, Nissen UV, Dufour A, Sahin M, Greer P, Kullander K, Mrsic-Flogel TD, Greenberg ME, Kiehn O, Vanderhaeghen P and Klein R: Regulation of EphA 4 kinase activity is required for a subset of axon guidance decisions suggesting a key role for receptor clustering in Eph function. Neuron 47: 515-528, 2005. (Pubitemid 41139210)
24. Taneja R, Thisse B, Rijli FM, Thisse C, Bouillet P, Chambon P: The expression pattern of the mouse receptor tyrosine kinase gene MDK1 is conserved through evolution and requires Hoxa-2 for rhombomere-specific expression in mouse embryos. Dev Biol 177: 397-412, 1996. (Pubitemid 26275893)
25. Ciossek T, Millauer B and Ulrich A: Identification of alternatively spliced mRNAs encoding variants of MDK1, a novel receptor tyrosine kinase expressed in the murine nervous system. Oncogene 10: 97-108, 1995.
26. Chen X, Wang J, Shen H, Lu J, Li C, Hu DN, Dong XD, Yan D and Tu L: Epigenetics, microRNAS, and carcinogenesis: functional role of microRNA-137 in uveal melanoma. Invest Ophthalmol Vis Sci 52: 1193-1199, 2011.